MedKoo Cat#: 414493 | Name: Transergan Free Base

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Transergan Free Base is a new spasmolytic

Chemical Structure

Transergan Free Base
Transergan Free Base
CAS# 82-00-8 (free base)

Theoretical Analysis

MedKoo Cat#: 414493

Name: Transergan Free Base

CAS#: 82-00-8 (free base)

Chemical Formula: C19H23ClN2O2S

Exact Mass: 378.1169

Molecular Weight: 378.92

Elemental Analysis: C, 60.23; H, 6.12; Cl, 9.36; N, 7.39; O, 8.44; S, 8.46

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
82-00-8 (free base); 298-51-1 (HCl)
Synonym
Transergan; Novazine; Transergan Free Base
IUPAC/Chemical Name
10H-Phenothiazine-10-carboxylic acid, 2-(diethylamino)ethyl ester, monohydrochloride
InChi Key
FOQGDCBIMVXYSR-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H22N2O2S.ClH/c1-3-20(4-2)13-14-23-19(22)21-15-9-5-7-11-17(15)24-18-12-8-6-10-16(18)21;/h5-12H,3-4,13-14H2,1-2H3;1H
SMILES Code
O=C(N1C2=C(C=CC=C2)SC3=CC=CC=C13)OCCN(CC)CC.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 378.92 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: ELIASSON S, TEJNING S. Clinical trials of transergan in the parkinsonian syndrome. Acta Med Scand. 1956 Jun 9;154(5):375-9. doi: 10.1111/j.0954-6820.1956.tb14332.x. PMID: 13326279. 2: JOHNSON SR. Transergan, ett nytt spasmolyticum; klinisk prövning [Transergan, a new spasmolytic; clinical trial]. Nord Med. 1955 Feb 17;53(7):265-7. Swedish. PMID: 14356481. 3: WIEDLING S. Pharmacological and toxicological studies on beta- diethylaminoethyl phenothiazine-10-carboxylate hydrochloride, transergan, a new spasmolytic and anti-parkinsonism agent. Acta Pharmacol Toxicol (Copenh). 1957;13(1):59-79. doi: 10.1111/j.1600-0773.1957.tb00239.x. PMID: 13381503. 4: Hellem S, Persson G, Freiberg N, Nord PG, Gustafsson B, Huitfeldt B. A model for evaluating the analgesic effect of a new fixed ratio combination analgesic in patients undergoing oral surgery. Int J Oral Surg. 1979 Dec;8(6):435-42. doi: 10.1016/s0300-9785(79)80082-4. PMID: 120341.